Drug Development

Clinical Trials | Drug Development | Information Technology

Virtual Clinical Trials: The Future of Dermatology Studies

COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.

Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News

EVOQ Therapeutics and Amgen Partner

Collaborate on the discovery and development of novel drugs for autoimmune disorders.

Contract Pharma Staff 01.13.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Adagene Achieves CAR-T Collaboration Milestone

Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.

Contract Pharma Staff 01.12.21

Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish

A New Era of Vaccine and Biologic Drug Development

As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.

Online Exclusives Kristin Brooks, Managing Editor 01.12.21

Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News

Cyclolab and EpiPharma Form Joint Venture

Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.

Contract Pharma Staff 01.11.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing

Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals

Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.

Contract Pharma Staff 01.08.21

Clinical Trials | Drug Development

The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.

Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

BrickBio Inks ADC Co-Development Deal

To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.

Contract Pharma Staff 01.06.21

Drug Development | Industry News | Regulatory Affairs

The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".

Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology

Lantern Pharma Launches ADC Program

Will leverage RADR artificial intelligence platform to target solid tumors and blood cancers through agreement with Califia Pharma.

Contract Pharma Staff 01.04.21

Clinical Trials | Drug Development

Impact of Decentralized Trials in Oncology Drug Development

Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.

01.04.21

Oncorus to Build GMP Viral Immunotherapy Mfg. Facility

88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.

Contract Pharma Staff 01.04.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec, BMS Advance Targeted Protein Degradation Projects

The first two targets transition into drug discovery after completing a comprehensive target validation process.

Contract Pharma Staff 12.17.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

INOVIO to Develop dMAb COVID Treatments under DARPA Grant

$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.

Contract Pharma Staff 12.15.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Lilly to Acquire Prevail Therapeutics in $1B Deal

Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.

Contract Pharma Staff 12.15.20

Breaking News | Clinical Trials | CRO News | Drug Development

Ergomed Acquires MedSource

Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.

Contract Pharma Staff 12.15.20

Clinical Trials | Drug Development | Information Technology

Advancing Digital Endpoints in Clinical Trials

An end-to-end approach to managing wearable devices through clinical development.

Online Exclusives Kristin Brooks, Contract Pharma 12.14.20

Clinical Trials | Drug Development | Information Technology

Advances in Intelligent Automation

The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.

Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20

Drug Development

Navigating Uncertainty: Considerations for Life Sciences 2021

With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.

Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20